Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Next Generation Veto Cells for Non-Myeloablative Haploidentical HSCT: Combining Anti-Viral and Graft Facilitating Activity

Esther Bachar Lustig, PhD, Noga Or Geva, PhD, Assaf Lask, PhD, Rotem Gidron, MD, Sivan Kagan, PhD, Aloukick Kumar Sinqh, PhD, Yair Reisner, PhD

Blood (2016) 128 (22): 3345.

https://doi.org/10.1182/blood.V128.22.3345.3345

Published: 2016

Journal Articles

Towards 'Off-the-Shelf ' Universal Chimeric Antigen Receptor (CAR) T Cells: Mouse Anti-3 rd Party Central Memory CD8 Veto Cells Prolong Functional Engraftment of Allogeneic Genetically Modified T Cells

Noga Or Geva, PhD, Rotem Gidron, MD, Aloukick Kumar Singh, PhD, Rakefet Sidlik Muskatel, MD, Yair Reisner, PhD

Blood (2016) 128 (22): 2171.

https://doi.org/10.1182/blood.V128.22.2171.2171

Published: 2016

Journal Articles

Transplantation of T Cell Depleted Haploidentical HSCT Following Non-Myeloablative (NMA) Conditioning: Combining the Power of Megadose Transplants with Post Transplant Cyclophosphamide (PTCY)

Franco Aversa, MD, Esther BacharLustig, PhD, Lucia Prezioso, MD PhD, Sabrina Bonomini, MSc, Noga Or Geva, PhD, Alessandro Monti, MD, Ilenia Manfra, MD, Chiara Schifano, MSc, Federica Galaverna, MD, Yael Zlotnikov Klionsky, PhD, Yair Reisner, PhD

Blood (2016) 128 (22): 5765.

https://doi.org/10.1182/blood.V128.22.5765.5765

Published: 2016

Journal Articles

Chimerism Induction Without GVHD Following Low Intensity Conditioning In MHC Disparate Recipients: Combining The Benefit Of Cyclophosphamide Post Transplant With The Tolerogenicity Of Megadose T Cell Depleted HSCT

Esther Bachar-Lustig, PhD, Noga Or-Geva, MSc, Yael Zlotnikov Klionsky, MSc, Yair Reisner, PhD

Blood (2013) 122 (21): 3238.

https://doi.org/10.1182/blood.V122.21.3238.3238

Published: 2013

Journal Articles

A new approach for eradication of residual lymphoma cells by host nonreactive anti–third-party central memory CD8 T cells

Assaf Lask, Eran Ophir, Noga Or-Geva, Adva Cohen-Fredarow, Ran Afik, Yaki Eidelstein, Shlomit Reich-Zeliger, Bar Nathansohn, Matthias Edinger, Robert S. Negrin, David Hagin, Yair Reisner

Blood (2013) 121 (15): 3033–3040.

https://doi.org/10.1182/blood-2012-06-432443

Published: 2013

Includes: Supplemental data

Journal Articles

Murine anti–third-party central-memory CD8 + T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells

Eran Ophir, Noga Or-Geva, Irina Gurevich, Orna Tal, Yaki Eidelstein, Elias Shezen, Raanan Margalit, Assaf Lask, Guy Shakhar, David Hagin, Esther Bachar-Lustig, Shlomit Reich-Zeliger, Andreas Beilhack, Robert Negrin, Yair Reisner

Blood (2013) 121 (7): 1220–1228.

https://doi.org/10.1182/blood-2012-07-441493

Published: 2013

Includes: Multimedia, Supplemental data

Journal Articles

Towards Clinically Feasible Co-Stimulatory Blockade for Tolerance Induction: Transient Treatment with CTLA4-Ig, Anti-CD48 and FTY720 Enables Durable Engraftment of T Cell Depleted BM Allografts Following Non-Myeloablative Conditioning.

Esther Bachar-Lustig, PhD, Dalit Tchorsh-Yutsis, PhD, Eran Ophir, MSc, Yael Zlotnikov Klionsky, MSc, Noga Or-Geva, BSc, Yair Reisner, PhD

Blood (2010) 116 (21): 3726.

https://doi.org/10.1182/blood.V116.21.3726.3726

Published: 2010

Journal Articles

Ex Vivo Generated Donor Central Memory CD8 T Cells, Previously Shown to Enhance Engraftment of Allogeneic Bone Marrow, Also Exhibit Significant GVL Activity without Causing Gvhd In An In Vivo b Cell Lymphoma Model

Assaf Lask, MSc, Eran Ophir, MSc, Noga Or-Geva, BSc, Adva Cohen, MSc, Ran Afik, MSc, Yaki Eidelstein, MSc, Robert Negrin, MD, Arnon Nagler, M.D., Alain Berrebi, MD, David Hagin, MD, Yair Reisner, PhD

Blood (2010) 116 (21): 424.

https://doi.org/10.1182/blood.V116.21.424.424

Published: 2010

NARROW

Next Generation Veto Cells for Non-Myeloablative Haploidentical HSCT: Combining Anti-Viral and Graft Facilitating Activity

Towards 'Off-the-Shelf ' Universal Chimeric Antigen Receptor (CAR) T Cells: Mouse Anti-3 rd Party Central Memory CD8 Veto Cells Prolong Functional Engraftment of Allogeneic Genetically Modified T Cells

Transplantation of T Cell Depleted Haploidentical HSCT Following Non-Myeloablative (NMA) Conditioning: Combining the Power of Megadose Transplants with Post Transplant Cyclophosphamide (PTCY)

Chimerism Induction Without GVHD Following Low Intensity Conditioning In MHC Disparate Recipients: Combining The Benefit Of Cyclophosphamide Post Transplant With The Tolerogenicity Of Megadose T Cell Depleted HSCT

A new approach for eradication of residual lymphoma cells by host nonreactive anti–third-party central memory CD8 T cells

Murine anti–third-party central-memory CD8 + T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells

Towards Clinically Feasible Co-Stimulatory Blockade for Tolerance Induction: Transient Treatment with CTLA4-Ig, Anti-CD48 and FTY720 Enables Durable Engraftment of T Cell Depleted BM Allografts Following Non-Myeloablative Conditioning.

Ex Vivo Generated Donor Central Memory CD8 T Cells, Previously Shown to Enhance Engraftment of Allogeneic Bone Marrow, Also Exhibit Significant GVL Activity without Causing Gvhd In An In Vivo b Cell Lymphoma Model

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only